Develop a new, minimally invasive structural heart repair product called Permaseal™, and begin commercializing it. The company designs, develops and commercializes proprietary technologies targeting unmet needs in the treatment of structural heart disease. The Permaseal closure device is intended to close myocardial punctures, incisions, and ostomies in structural heart repair procedures. This product will serve the large market of surgical patients who are currently unable to undergo high-risk procedures, particularly for the increasingly popular Transcatheter Aortic Valve Implantation procedure (TAVI).
Clients
Micro Interventional Devices
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.